Earnings Roundup: Specialty/Smaller Biopharmas See Modest Hit From Pandemic

Business report
Smaller companies reported some similar Q1 pandemic impacts as their larger peers
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business